Pharma Mar SA
Pablo B. is a Senior Scientist at PharmaMar, with extensive experience in the pharmaceutical industry since July 1998. Responsibilities include drafting CMC sections for regulatory documents related to clinical trials and marketing applications, as well as liaising with partners and CROs. Previously, Pablo B. served as Head of the Department of Production of Natural Products, overseeing outsourced manufacturing, developing scalable processes, and performing isolation and structural elucidation of active ingredients. Prior to PharmaMar, Pablo B. held a Senior Scientist position at Universidad de Santiago de Compostela, focusing on the synthesis of intermediates for active pharmaceutical ingredients. Education includes a Licentiate degree in Organic Chemistry from Universidad de Santiago de Compostela, a Doctorate in Organic Chemistry, and multiple research positions that further developed expertise in synthetic organic chemistry, supported by the attainment of a European Expert on Quality Management certification.
This person is not in the org chart
This person is not in any offices
Pharma Mar SA
Pharma Mar SA is a Spain-based company engaged in the bio therapeutic drugs manufacture. The Company focuses on research, development and marketing of bio-active principles, primarily from marine origin, for application in human diseases treatment, including antitumour, antiviral and immunomodulation, as well as tropical diseases areas. It manufactures and sells Yondelis, a synthetically modified antitumor agent, which is derived from sea squirts and is implemented in the treatment of soft tissue sarcomas and relapsed ovarian cancer. Furthermore, the Company's products pipeline comprises drug candidates and agents for cancer treatment, such as Aplidin, PM01183 and PM060184. The Company operates through subsidiaries in Italy, Germany, France, and the United States, among others.